PHARMACY

Christie Boutte to join NACDS as director of Policy and Programs

BY Adam Kraemer

ALEXANDRIA, Va. Industry veteran Christie Boutte has been hired by the National Association of Chain Drug Stores as director of Policy and Programs.

Boutte, who will serve NACDS as an expert on such healthcare programs as Medicare, Medicaid and the State Children’s Health Insurance Program, most recently held the position of clinical program manager for Medicare Part D administration at CIGNA HealthCare. Prior to that, she spent four years at the Centers for Medicare and Medicaid Services in the Office of Clinical Standards and Quality for Medicare, as well as the Center for Medicaid and State Operations.

“Christie’s background is ideally suited for her position,” said NACDS president and chief executive officer Steve Anderson. ”Her expertise will be a tremendous asset to NACDS, and we are very excited to have Christie on our team.”

After receiving her Doctor of Pharmacy degree from Xavier University, Boutte worked as a pharmacist at several NACDS member companies. She will report to Julie Helm Khani, NACDS’ vice president of Federal Health Care Programs.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

FDA requests delay on Merck application for cholesterol drugs

BY Alaric DeArment

BOSTON The Food and Drug Administration has recommended that Merck wait until it finishes clinical trials of the cholesterol drugs MK-0524A and MK-0524B before re-filing a marketing application for them, Merck announced Friday.

The FDA rejected Merck’s application for the two drugs in April, and the FDA has advised that it should wait until it receives results from the clinical trial before re-filing.

MK-0524A is a combination of the drug Cordaptive and niacin; MK-0524B combines those ingredients with Zocor. Merck has said it does not plan to seek approval for MK-0524B until it completes the application for MK-0524A.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Adheris’ Glaser dies at 53

BY DSN STAFF

BURLINGTON, Mass. Matthew Glaser, 53, senior vice president of Professional Services for Adheris, passed away from cancer this past Saturday.

Glaser was a respected leader in the retail pharmacy industry who spent over 30 years working in community, chain, hospital and institutional pharmacy settings. Since 1996, he had dedicated his experience and skills to growing Adheris from a start-up to a leading provider of pharmacy-based patient education and adherence programs. At Adheris, he worked with chain and independent pharmacies, ensuring the delivery of appropriate compliance and adherence programs to their patients.

Prior to his tenure at Adheris, Glaser served as vice president of Pharmacy and Professional Affairs for Brooks Pharmacy, and as assistant vice president of Professional Services and vice president of Managed Care at Hook-SupeRx. Earlier in his career, he spent several years serving in various management positions at CVS.

Glaser held a Bachelor of Science degree in Pharmacy from Northeastern University.

Glaser is survived by his four children; his mother and several siblings and nieces and nephews. Memorial contributions may be made in his memory to the Matthew P. Glaser Memorial Scholarship Fund at the Massachusetts College of Pharmacy, Office of Advancement at 179 Longwood Ave., Boston, MA 02115.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES